|
US7141244B1
(en)
*
|
1992-03-02 |
2006-11-28 |
Chiron Srl |
Helicobacter pylori proteins useful for vaccines and diagnostics
|
|
JPH10502366A
(ja)
*
|
1994-07-01 |
1998-03-03 |
リカン・リミテッド |
ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
|
|
GB2324093A
(en)
*
|
1996-01-04 |
1998-10-14 |
Rican Limited |
Helicobacter pylori bacterioferritin
|
|
EP1860192A1
(en)
|
1996-09-17 |
2007-11-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
EP2210945B1
(en)
*
|
1998-01-14 |
2013-06-26 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisseria meningitidis antigens
|
|
EP2261339B1
(en)
|
1998-05-01 |
2017-03-22 |
GlaxoSmithKline Biologicals SA |
Neisseria meningitidis antigens and compositions
|
|
US6610306B2
(en)
*
|
1998-10-22 |
2003-08-26 |
The University Of Montana |
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
|
|
EP2374889A3
(en)
*
|
1998-12-08 |
2012-02-22 |
GlaxoSmithKline Biologicals SA |
Novel compounds
|
|
CN1375006A
(zh)
|
1999-01-22 |
2002-10-16 |
史密丝克莱恩比彻姆生物有限公司 |
新型化合物
|
|
CA2365102A1
(en)
|
1999-03-12 |
2000-09-21 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
|
|
JP2003527079A
(ja)
*
|
1999-04-30 |
2003-09-16 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
|
CN100392082C
(zh)
|
1999-04-30 |
2008-06-04 |
启龙股份公司 |
保守的奈瑟球菌抗原
|
|
DK2270173T3
(en)
|
1999-05-19 |
2016-03-07 |
Glaxosmithkline Biolog Sa |
Neisserial combination compositions
|
|
AU2013203304B2
(en)
*
|
1999-05-19 |
2014-10-09 |
Glaxosmithkline Biologicals S.A. |
Combination Neisserial compositions
|
|
AU2003271337B2
(en)
*
|
1999-08-03 |
2005-07-21 |
Smithkline Beecham Biologicals S.A. |
Vaccine composition
|
|
DK1801219T3
(en)
|
1999-10-29 |
2015-12-07 |
Glaxosmithkline Biolog Sa |
Neisseriale antigenic peptides.
|
|
WO2001038350A2
(en)
*
|
1999-11-29 |
2001-05-31 |
Chiron Spa |
85kDa NEISSERIAL ANTIGEN
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
RU2279889C2
(ru)
|
2000-01-17 |
2006-07-20 |
Чирон С.Р.Л. |
ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В
|
|
EP2270031A3
(en)
|
2000-02-28 |
2011-02-16 |
Novartis Vaccines and Diagnostics S.r.l. |
Heterologous expression of neisserial proteins
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
GB0012079D0
(en)
*
|
2000-05-18 |
2000-07-12 |
Microscience Ltd |
Virulence gene and protein, and their use
|
|
BRPI0112928B1
(pt)
|
2000-07-27 |
2017-08-29 |
Children's Hospital & Research Center At Oakland |
A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV
|
|
GB0020952D0
(en)
*
|
2000-08-24 |
2000-10-11 |
Microscience Ltd |
Genes and proteins and their uses
|
|
AU2002219032A1
(en)
*
|
2000-09-09 |
2002-03-26 |
Degussa A.G. |
Nucleotide sequences which code for the dep34 gene
|
|
WO2002034771A2
(en)
|
2000-10-27 |
2002-05-02 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
CA2452836C
(en)
|
2001-07-27 |
2012-11-27 |
Chiron Srl |
Meningococcus adhesins nada, app and orf 40
|
|
WO2003018054A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Chiron Srl. |
Helicobacter pylori vaccination
|
|
EP1438323A4
(en)
*
|
2001-10-03 |
2007-08-01 |
Novartis Vaccines & Diagnostic |
ADJUVOUS MENINGOCOCCUS COMPOSITIONS
|
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
US20050106162A1
(en)
|
2001-12-12 |
2005-05-19 |
Guido Grandi |
Immunisation against chlamydia trachomatis
|
|
US7501134B2
(en)
|
2002-02-20 |
2009-03-10 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
|
EP1495039A4
(en)
*
|
2002-03-20 |
2006-07-26 |
Univ Emory |
MUTANTS OF NEISSERIA, LIPOOLIGOSACCHARIDES AND IMMUNOGENIC COMPOSITIONS
|
|
SI2255826T1
(sl)
*
|
2002-08-02 |
2016-07-29 |
Glaxosmithkline Biologicals S.A. |
Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0220205D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Neisseria toxin
|
|
AU2003274511B2
(en)
|
2002-10-11 |
2009-06-04 |
Glaxosmithkline Biologicals S.A. |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
|
JP2006504801A
(ja)
|
2002-11-01 |
2006-02-09 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乾燥方法
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
CA2511512C
(en)
|
2002-12-27 |
2013-10-29 |
Chiron Corporation |
Immunogenic compositions containing phospholipid
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
ES2596553T3
(es)
|
2003-06-02 |
2017-01-10 |
Glaxosmithkline Biologicals Sa |
Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
RU2378010C2
(ru)
|
2003-10-02 |
2010-01-10 |
Новартис Вэксинес Энд Дайэгностикс С.Р.Л. |
Жидкие вакцины для множественных серогрупп менингококков
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
EP2277595A3
(en)
|
2004-06-24 |
2011-09-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compounds for immunopotentiation
|
|
EP1784211A4
(en)
|
2004-07-29 |
2010-06-30 |
Novartis Vaccines & Diagnostic |
IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
|
|
US9034345B2
(en)
|
2005-01-27 |
2015-05-19 |
Children's Hospital & Research Center Oakland |
GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
|
CN101355960A
(zh)
|
2005-10-18 |
2009-01-28 |
诺华疫苗和诊断公司 |
使用α病毒复制子颗粒进行粘膜和全身免疫
|
|
WO2007081447A2
(en)
|
2005-11-22 |
2007-07-19 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
ES2376492T3
(es)
|
2006-03-23 |
2012-03-14 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores.
|
|
RU2450019C2
(ru)
|
2006-06-29 |
2012-05-10 |
Новартис Аг |
Полипептиды из neisseria meningitidis
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
CN101969992B
(zh)
|
2007-09-12 |
2014-10-01 |
诺华股份有限公司 |
Gas57突变型抗原和gas57抗体
|
|
US20100285069A1
(en)
|
2007-10-19 |
2010-11-11 |
Mario Contorni |
Meningococcal vaccine formulations
|
|
AU2008335457B2
(en)
|
2007-12-07 |
2015-04-16 |
Glaxosmithkline Biologicals S.A. |
Compositions for inducing immune responses
|
|
PL2235046T3
(pl)
|
2007-12-21 |
2012-12-31 |
Novartis Ag |
Zmutowane formy streptolizyny O
|
|
US9579372B2
(en)
|
2008-02-21 |
2017-02-28 |
Glaxosmithkline Biologicals Sa |
Meningococcal fHBP polypeptides
|
|
MX2010009738A
(es)
|
2008-03-03 |
2010-09-30 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de tlr.
|
|
JP5689064B2
(ja)
|
2008-10-27 |
2015-03-25 |
ノバルティス アーゲー |
精製方法
|
|
WO2010057069A1
(en)
|
2008-11-14 |
2010-05-20 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection campylobacter nucleic acid
|
|
AU2010203223B9
(en)
|
2009-01-05 |
2015-10-08 |
Epitogenesis Inc. |
Adjuvant compositions and methods of use
|
|
CA2749367A1
(en)
|
2009-01-12 |
2010-07-15 |
Novartis Ag |
Cna_b domain antigens in vaccines against gram positive bacteria
|
|
BRPI1009828A2
(pt)
|
2009-03-24 |
2019-03-12 |
Novartis Ag |
adjuvante de proteína de ligação de fator h meningocócica
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
JP5867952B2
(ja)
|
2009-06-10 |
2016-02-24 |
ノバルティス アーゲー |
ベンゾナフチリジン含有ワクチン
|
|
JO3257B1
(ar)
|
2009-09-02 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات كمعدلات لفاعلية tlr
|
|
JP5988492B2
(ja)
|
2009-09-02 |
2016-09-07 |
ノバルティス アーゲー |
Ｔｌｒ活性モジュレーターを含む免疫原性組成物
|
|
JP2013506651A
(ja)
|
2009-09-30 |
2013-02-28 |
ノバルティス アーゲー |
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ．ａｕｒｅｕｓ５型および８型莢膜多糖の結合体
|
|
CN102971009A
(zh)
|
2009-10-30 |
2013-03-13 |
诺华有限公司 |
金黄色葡萄球菌5型和8型荚膜多糖的纯化
|
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
|
CA2784580A1
(en)
|
2009-12-15 |
2011-07-14 |
Novartis Ag |
Homogeneous suspension of immunopotentiating compounds and uses thereof
|
|
AU2011232421B2
(en)
|
2010-03-23 |
2015-08-13 |
Novartis Ag |
Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
|
|
JP2013532008A
(ja)
|
2010-05-28 |
2013-08-15 |
テトリス オンライン インコーポレイテッド |
対話式ハイブリッド非同期コンピュータ・ゲーム・インフラストラクチャ
|
|
US10478483B2
(en)
|
2010-06-25 |
2019-11-19 |
Glaxosmithkline Biologicals Sa |
Combinations of meningococcal factor H binding proteins
|
|
MX350142B
(es)
|
2010-08-23 |
2017-08-28 |
Wyeth Llc * |
Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
|
|
GB201014967D0
(en)
*
|
2010-09-09 |
2010-10-20 |
Univ Southampton |
Composition
|
|
SG187912A1
(en)
|
2010-09-10 |
2013-04-30 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
CA2810971C
(en)
|
2010-09-10 |
2020-11-03 |
Novartis Ag |
Developments in meningococcal outer membrane vesicles
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
EP2655389A2
(en)
|
2010-12-24 |
2013-10-30 |
Novartis AG |
Compounds
|
|
JP6499446B2
(ja)
|
2011-06-24 |
2019-04-10 |
エピットジェネシス・インコーポレーテッド |
抗原特異的免疫モジュレーターとして選択担体、ビタミン、タンニンおよびフラボノイドの組み合わせを含有する医薬組成物
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
US8986710B2
(en)
|
2012-03-09 |
2015-03-24 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
RU2644340C2
(ru)
|
2012-06-14 |
2018-02-08 |
Новартис Аг |
Вакцины для менингококка серогруппы х
|
|
HK1205138A1
(en)
|
2012-07-27 |
2015-12-11 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
SG11201500978TA
(en)
|
2012-10-03 |
2015-07-30 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
CN105492021B
(zh)
|
2013-09-08 |
2018-12-04 |
辉瑞公司 |
脑膜炎奈瑟氏球菌组合物及其方法
|
|
US10888611B2
(en)
|
2015-02-19 |
2021-01-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
BE1024634B1
(fr)
|
2016-04-05 |
2018-05-14 |
Gsk Vaccines S.R.L. |
Compositions immunogenes
|
|
MX372587B
(es)
|
2017-01-31 |
2020-04-17 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
US11464845B2
(en)
|
2017-07-21 |
2022-10-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neisseria meningitidis immunogenic compositions
|
|
EP3694535B1
(en)
*
|
2017-10-11 |
2025-11-26 |
Elanco US Inc. |
Porcine g-csf variants and their uses
|
|
CN109161546B
(zh)
*
|
2018-09-20 |
2021-11-09 |
广西科学院 |
一种核酸适配体及其在检测卵形鲳鲹源致病性溶藻弧菌中的应用
|
|
CN115605222A
(zh)
|
2019-09-27 |
2023-01-13 |
辉瑞公司（Us） |
脑膜炎奈瑟氏菌组合物及其方法
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|